Your shopping cart is currently empty

Sifuvirtide (SFT) acetate is a potent inhibitor of HIV fusion. It effectively inhibits HIV-1-mediated cell fusion in a dose-dependent manner and demonstrates high efficacy against infections caused by both primary and laboratory-adapted HIV-1 isolates of various genotypes. Sifuvirtide acetate is applicable in the research of anti-HIV drugs.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $83 | 7-10 days | 7-10 days | |
| 5 mg | Preferential | 7-10 days | 7-10 days |
| Description | Sifuvirtide (SFT) acetate is a potent inhibitor of HIV fusion. It effectively inhibits HIV-1-mediated cell fusion in a dose-dependent manner and demonstrates high efficacy against infections caused by both primary and laboratory-adapted HIV-1 isolates of various genotypes. Sifuvirtide acetate is applicable in the research of anti-HIV drugs. |
| Synonyms | Sifuvirtide acetate, SFT acetate |
| Molecular Weight | 4727.98 (free base) |
| Formula | C203H309N59O72.xC2H4O2 |
| Sequence | Ac-Ser-Trp-Glu-Thr-Trp-Glu-Arg-Glu-Ile-Glu-Asn-Tyr-Thr-Arg-Gln-Ile-Tyr-Arg-Ile-Leu-Glu-Glu-Ser-Gln-Glu-Gln-Gln-Asp-Arg-Asn-Glu-Arg-Asp-Leu-Leu-Glu |
| Sequence Short | SWETWEREIENYTRQIYRILEESQEQQDRNERDLLE |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.